Related Experiment Video
Updated: Jul 20, 2025
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
From bedside to the bench: patient-specific hiPSC-EC models uncover endothelial dysfunction in genetic
Martina Rabino1, Elena Sommariva1, Serena Zacchigna2,3,4
1Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino-IRCCS, Milan, Italy.
Insights
Human induced pluripotent stem cell-derived endothelial cells offer a novel model for studying genetic cardiomyopathies. Research highlights their potential in uncovering endothelial dysfunction mechanisms and identifying new therapeutic targets.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Genetics
Background:
- Genetic cardiomyopathies are inherited disorders affecting heart muscle structure and function.
- Patient-specific stem cell models are crucial due to rare, heterogeneous disease phenotypes.
- Endothelial dysfunction is implicated, but human induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs) are understudied.
Purpose of the Study:
- To review studies utilizing hiPSC-ECs for investigating endothelial dysfunction in genetic cardiomyopathies.
- To identify novel therapeutic targets by dissecting the role of endothelial cells.
- To discuss future research directions for hiPSC-EC models in this field.
Main Methods:
- Review of existing literature on hiPSC-ECs and genetic cardiomyopathies.
- Analysis of studies focusing on endothelial dysfunction mechanisms.
- Identification of potential therapeutic targets from reviewed research.
Main Results:
- hiPSC-ECs provide a valuable model for studying endothelial dysfunction in genetic cardiomyopathies.
- These models facilitate the dissection of endothelial cell roles in disease pathogenesis.
- The reviewed studies suggest potential new targets for therapeutic intervention.
Conclusions:
- hiPSC-ECs are a promising, yet underutilized, model for genetic cardiomyopathy research.
- Further investigation into hiPSC-ECs can reveal critical insights into endothelial dysfunction.
- This research avenue holds potential for developing novel therapeutic strategies.
Abstract:
Genetic cardiomyopathies are a group of inherited disorders in which myocardial structure and function are damaged. Many of these pathologies are rare and present with heterogenous phenotypes, thus personalized models are required to completely uncover their pathological mechanisms and develop valuable therapeutic strategies. Both cardiomyocytes and fibroblasts, differentiated from patient-specific human induced pluripotent stem cells, represent the most studied human cardiac cell models in the context of genetic cardiomyopathies. While endothelial dysfunction has been recognized as a possible pathogenetic mechanism, human induced pluripotent stem cell-derived endothelial cells are less studied, despite they constitute a suitable model to specifically dissect the role of the dysfunctional endothelium in the development and progression of these pathologies. In this review, we summarize the main studies in which human induced pluripotent stem cell-derived endothelial cells are used to investigate endothelial dysfunction in genetic-based cardiomyopathies to highlight new potential targets exploitable for therapeutic intervention, and we discuss novel perspectives that encourage research in this direction.
More Related Videos
08:37Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
06:36An In Vitro 3D Model and Computational Pipeline to Quantify the Vasculogenic Potential of iPSC-Derived Endothelial Progenitors
Published on: May 13, 2019
